Rheumatology Highlights Report

 

Rheumatology Highlights Report

Crystalline Arthritis

Print this Content

 

 

How to Obtain AMA PRA
Category 1 Credit

  1. Watch the activity on your computer or mobile device.
  2. Complete the CME posttest (each question must be answered correctly).
  3. Login to your account.
  4. Complete the credit and evaluation form.
  5. Print your personalized CME certificate.

Technical Requirements

 

Release Date:   January 9, 2012
Expiration Date:   January 9, 2013

Estimated Time of Completion:  15 minutes

Description

The Rheumatology Highlights Report Series is designed for the busy clinician. It provides highlights from key scientific presentations and/or abstracts presented at the national rheumatology meeting. Clinical experts attending this meeting have selected the most significant data to report. Each activity is a 15-minute presentation. Enhancements include downloadable audio and slide sets, and supporting abstracts with expert commentaries. This series offers two methods of participation: on your computer or mobile device.

Learning Objectives

  1. Recognize emerging technologies that may aid in the diagnosis of gout and quantifying the burden of urate deposits.
  2. Identify the correlation between gout/hyperuricemia and the co-morbid conditions of coronary artery disease and kidney disease.
  3. Develop safer prescribing habits for urate-lowering therapies.

Target Audience

This activity is directed to rheumatologists, immunologists, rheumatology and immunology fellows, clinical researchers, and rheumatology and immunology allied health professionals, including nurse practitioners and physician assistants.

Accreditation

The Cleveland Clinic Foundation Center for Continuing Education is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

The Cleveland Clinic Foundation Center for Continuing Education designates this enduring material for a maximum of 0.25 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Participants claiming CME credit from this activity may submit the credit hours to the American Osteopathic Association Council on Continuing Medical Education for Category 2 credit.

Activity Director

Leonard H. Calabrese, DO
Professor of Medicine
Cleveland Clinic Lerner College of Medicine of Case Western Reserve University
R.J. Fasenmyer Chair of Clinical Immunology
Vice Chairman, Department of Rheumatic and Immunologic Diseases
Orthopaedic and Rheumatologic Institute
Cleveland Clinic
Cleveland, Ohio

Faculty

N. Lawrence Edwards, MD
Professor of Medicine and Residency Program Director
Vice Chairman, Department of Medicine
University of Florida
Chief, Rheumatology Section
Veterans Administration Medical Center
Gainesville, Florida

Disclosure

In accordance with the Standards for Commercial Support issued by the Accreditation Council for Continuing Medical Education (ACCME), the Cleveland Clinic Foundation Center for Continuing Education requires resolution of all faculty conflicts of interest to ensure CME activities are free of commercial bias.

The following faculty has indicated that he may have a relationship which, in the context of his presentation, could be perceived as a potential conflict of interest:

Leonard H. Calabrese, DO
  Abbott Laboratories; Amgen, Inc.; Centocor; Genentech/Roche; PfizerConsulting, Teaching & Speaking
  BMS; Elan Pharmaceuticals, Inc.; Wyeth Consulting

The following faculty has indicated that he has no relationship which, in the context of his presentation, could be perceived as a potential conflict of interest:

         N. Lawrence Edwards, MD

The Cleveland Clinic Foundation Center for Continuing Education acknowledges educational grants
for partial support of this activity from:

Amgen, Inc.
Pfizer, Inc.
Abbott Laboratories, Inc.

Genentech and Biogen Idec
UCB, Inc
Human Genome Sciences, Inc.

This CME activity was produced by The Cleveland Clinic Foundation Center for Continuing Education
and the RJ Fasenmyer Center for Clinical Immunology.

CME Disclaimer